Connection

SHELDON KAPLAN to Follow-Up Studies

This is a "connection" page, showing publications SHELDON KAPLAN has written about Follow-Up Studies.
Connection Strength

0.145
  1. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2005 May; 24(5):457-8.
    View in: PubMed
    Score: 0.031
  2. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J. 2003 Aug; 22(8):677-86.
    View in: PubMed
    Score: 0.028
  3. Follow-up Blood Cultures in Children With Staphylococcus aureus Bacteremia. Pediatrics. 2020 12; 146(6).
    View in: PubMed
    Score: 0.023
  4. Hepatosplenic abscesses due to Brucella melitensis: report of a case involving a child and review of the literature. Clin Infect Dis. 1996 Mar; 22(3):485-9.
    View in: PubMed
    Score: 0.016
  5. Presumed central nervous system Whipple's disease in a child: case report. Clin Infect Dis. 1995 Apr; 20(4):883-9.
    View in: PubMed
    Score: 0.015
  6. Follow-up of prospective randomized trial of ampicillin or chloramphenicol versus moxalactam treatment of Haemophilus influenzae type b meningitis. J Pediatr. 1988 May; 112(5):795-8.
    View in: PubMed
    Score: 0.010
  7. Citrobacter diversus and neonatal brain abscess. Pediatr Neurol. 1987 May-Jun; 3(3):178-80.
    View in: PubMed
    Score: 0.009
  8. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003 Jul; 22(7):593-8.
    View in: PubMed
    Score: 0.007
  9. Treatment of acute otitis media consensus recommendations. Clin Pediatr (Phila). 2002 Jul-Aug; 41(6):373-90.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.